Streetbeat News

Products Services

BABA

BIDU

FXI

KWEB

PDD

Alibaba Group Holding Limited (NYSE:BABA) stock is trading lower in line with the broader indexes IShares China Large-Cap ETF (NYSE:FXI) and KraneShares Trust KraneShares CSI China Internet ETF (NYSE:KWEB). The stocks got some respite Tuesday from PDD Holdings Inc’s (NASDAQ:PDD) upbeat second-quarter results before a selloff. Alibaba, along with other Chinese chip design firms, have formed a patent protection alliance for RISC-V and open-source chip ecosystem to beat the U.S. tech sanctions. Alibaba Cloud also launched a digital transformation lab in Japan.

Portfolio Pulse from Anusuya Lahiri

August 30, 2023 | 12:50 pm

ALBT

Avalon GloboCare Corp's subsidiary, Laboratory Services MSO, has launched a new in-house laboratory-developed test for tuberculosis. The test uses a patient's sputum sample and can be performed in under 2 hours, requiring only one visit to the clinic. Avalon owns a 40% interest in Laboratory Services.

Portfolio Pulse from Vandana Singh

August 30, 2023 | 12:46 pm

AVCO

Avalon GloboCare has announced that its new test method is expected to generate revenue in 2023. The company has not provided further details about the test method or its potential impact on the company's overall revenue.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 12:45 pm

AVCO

Avalon GloboCare's subsidiary, Laboratory Services MSO, LLC, has announced that it is now offering an in-house laboratory developed test to detect Tuberculosis using a patient's sputum sample.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 12:45 pm

WBD

Warner Bros. Discovery Inc (NASDAQ:WBD) is reportedly close to appointing Mark Thompson, former executive at the New York Times and the BBC, as the new CEO of CNN. This move is seen as a strategy to combat CNN's prolonged ratings decline. Thompson's tenure at the New York Times was marked by a successful transformation, including the achievement of 10 million paying subscribers ahead of schedule. His appointment comes as Warner Bros. Discovery seeks to rejuvenate CNN and align its traditional TV business with its digital growth objectives.

Portfolio Pulse from Anusuya Lahiri

August 30, 2023 | 12:42 pm

DGX

Quest Diagnostics has been granted FDA breakthrough designation for its Adeno-Associated Virus (AAV) test. Additionally, Quest has expanded its collaboration with Sarepta Therapeutics to develop AAV Companion Diagnostics for Sarepta's gene therapies.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 12:41 pm

EDTK

Skillful Craftsman Education Technology Limited (NASDAQ:EDTK) has announced a collaborative agreement with Parkway College of Nursing and Allied Health Pte. to provide specialized training for foreign workers seeking healthcare sector employment in Singapore. The collaboration aims to address the shortage of nursing resources in Singapore. Skillful Craftsman will utilize Parkway College's preparatory course to offer systematic trainings to overseas nurses. Singapore plans to hire close to 4,000 nurses by the end of 2023, 60% of which will be foreign nurses.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 12:39 pm

JAGX

Jaguar Health, Inc. (NASDAQ:JAGX) is focusing on developing its plant-based prescription drug, crofelemer, for two rare disease indications, short bowel syndrome (SBS) and microvillus inclusion disease (MVID). The company is supporting proof-of-concept studies in the US, EU, and Middle East/North Africa regions, with results expected by the end of 2023 and in 2024. The FDA and the European Medicines Agency have granted Orphan Drug Designation for crofelemer for both MVID and SBS.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 12:37 pm

ONDS

Ondas Holdings Inc. (NASDAQ:ONDS) has been awarded a grant of approximately $540,000 by the Israel Innovation Authority to support the development of its Iron Drone Raider counter-drone system, owned by its subsidiary Airobotics LTD. The system uses AI technologies to identify and intercept hostile drones and can be integrated into a variety of drone detection systems. The grant will fund a development program to enhance the system's capabilities for intercepting hostile drones in civil environments.

Portfolio Pulse from Happy Mohamed

August 30, 2023 | 12:37 pm

AZYO

Aziyo Biologics has announced the publication of a CanGaroo case study that demonstrates the benefits of Bioenvelope for reoperative procedures. The case provides the first histologic evidence that CanGaroo can catalyze the development of new healthy tissue layer within an existing cardiac implantable electronic device (CIED) pocket.

Portfolio Pulse from Benzinga Newsdesk

August 30, 2023 | 12:37 pm